Wen Xie
- University of Pittsburgh · Pharmacology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #11,151
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7365315Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$1.8M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#11,151
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Wen Xie as a PI. Multi-PI records show the full award amount for context.
- 5R35ES030429-08R35Contact PIXenobiotic Receptors in Mediating the Environmental Effects on Human Disease and MorbidityUniversity of Pittsburgh · Pharmacology (NIH department code)$802.2Kaward amount
- 1R01DK145468-01A1R01Contact PIOxidoreductase Sulfiredoxin 1 (SRXN1) and Protein Sulfinylation in Drug-Induced Acute Liver FailureUniversity of Pittsburgh · Pharmacology (NIH department code)$597.7Kaward amount
- 5R01DK135538-04R01Contact PICellular and Metabolic Basis of the Role of CYP1B1 in Liver FibrosisUniversity of Pittsburgh · Pharmacology (NIH department code)$416.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Wen Xie as a PI.
FY2026 award administered by University of Pittsburgh (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Pittsburgh
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder